Mod­er­na's Ted Ash­burn jumps to the helm at On­corus; Ar­row­head pock­ets $10M as Am­gen dos­es first pa­tient with its car­dio drug

→ On­corus, a Cam­bridge, MA-based biotech fo­cused on on­colyt­ic virus­es, has snagged Mod­er­na’s chief of on­col­o­gy de­vel­op­ment for the helm. Ted Ash­burn is tak­ing the CEO’s spot while On­corus’ co-founder and MPM Cap­i­tal man­ag­ing di­rec­tor Mitchell Fin­er will call the strate­gic shots as ex­ec­u­tive chair­man. Ash­burn got his MD at Har­vard Med and went on to work at sev­er­al big or­ga­ni­za­tions, in­clud­ing Pfiz­er and Sanofi/Gen­zyme.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER